RH1 (NSC 697726) is a bioreductive prodrug investigated for its anticancer properties. It demonstrates a concentration-dependent dual response in vitro, triggering cellular senescence at lower concentrations and apoptotic cell death at higher doses. This compound is utilized in cancer research, particularly in studies exploring hypoxia-targeted therapies and mechanisms of cell fate.
Molecular Weight:
234.25
Purity:
99.15% (May vary between batches)
CAS Number:
[221635-42-3]
Formula:
C12H14N2O3
Target:
Others,Apoptosis
Application Notes:
Solubility: DMSO:1 mg/mL (4.27 mM)
* VAT and and shipping costs not included. Errors and price changes excepted